Biocon Limited has informed the Exchange regarding a press release dated August 08, 2024, titled "Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr".
Press Release Aug 08 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Biocon
- Press Release May 24 2024
- Press Release May 21 2024
- Press Release May 16 2024
- Press Release May 13 2024
- Press Release Apr 17 2024
Later from Biocon
- Biocon Limited Press Release Aug 29 2024
- Press Release Sep 25 2024
- Press Release Sep 26 2024
- Biocon Limited partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 products in the Middle East region
- Biocon Limited Press Release Oct 03 2024
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon